Association of rs11081062 polymorphism of DLGAP1 gene and levels of SLC1A1 protein with obsessive-compulsive disorder.
Efruz İrem AkkuşBurcu BayoğluNeşe KocabaşoğluJansed Berfin YıldızMüjgan CengizPublished in: Nucleosides, nucleotides & nucleic acids (2024)
Glutamate is an important neurotransmitter known to be effective in obsessive-compulsive disorder (OCD). The aim of this study is to investigate the relationship between the DLGAP1 gene encoding the scaffold protein of ionotropic glutamate receptors and the SLC1A1 gene encoding the glutamate transporter protein with OCD. Study groups consisted of 95 patients with OCD and 100 healthy controls. The severity of OCD in the patient group was determined by using the Y-BOCS. Single nucleotide polymorphisms of rs11081062 (C/T) in DLGAP1 and rs587777696 (C/T) in SLC1A1 were analyzed by real-time PCR. Levels of SLC1A1 protein were determined by ELISA. A significant difference was found between genotype distributions of rs11081062 in DLGAP1 in study groups ( p < 0.001). No significant association was found rs587777696 in SLC1A1 in OCD patients and controls. SLC1A1 protein levels were found to be lower in OCD patients compared to controls ( p = 0.005). According to OCD risk estimates for genotypes distributions of rs11081062 in DLGAP1 , having CT + TT genotypes was associated with the occurrence of sexual and religious obsessions and counting compulsions ( p = 0.038, OR = 2.98; p = 0.033, OR = 3.43; p = 0.035, OR = 2.66, respectively). CT genotype in DLGAP1 rs11081062 polymorphism was found to increase the risk of OCD in the female gender ( p = 0.042, OR = 3.01). This study suggests that rs11081062 in DLGAP1 may be associated with OCD and that SLC1A1 protein levels may be involved in the occurrence of OCD. We believe that our research can contribute to the understanding of the importance of glutamate in OCD.
Keyphrases
- obsessive compulsive disorder
- deep brain stimulation
- end stage renal disease
- ejection fraction
- protein protein
- computed tomography
- chronic kidney disease
- newly diagnosed
- risk assessment
- mental health
- binding protein
- prognostic factors
- copy number
- magnetic resonance
- gene expression
- magnetic resonance imaging
- small molecule
- patient reported outcomes
- positron emission tomography
- tissue engineering
- dual energy